China Health Group Inc. (8225.HK)
HKSE · HKD · Healthcare · Diagnostics & Research
HK$0.063 (+0.00%) as of
Key statistics
- Market cap
- 62.71M
- EPS (TTM)
- -0.010
- Dividend yield
- 0.00%
- 52-week range
- 0.063 – 0.164
- Beta
- -0.31
- Revenue (TTM)
- 29.9M
- Profit margin
- -47.38%
- Volume
- 20.00k
About China Health Group Inc.
China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Beijing, China
- Employees
- 33
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.